Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity-Reference-Cited by-同舟云学术

Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity

Published:2021-06 Issue:3 Volume:2 Page:428-439
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Papadopoulou Anastasia¹^ORCID,Koukoulias Kiriakos¹²,Alvanou Maria¹,Papadopoulos Vassilios K.³,Bousiou Zoe¹,Kalaitzidou Vasiliki¹,Kika Fotini S.¹,Papalexandri Apostolia¹,Mallouri Despina¹,Batsis Ioannis¹,Sakellari Ioanna¹,Anagnostopoulos Achilles¹,Yannaki Evangelia¹⁴

Affiliation:

1. Hematology Department‐Hematopoietic Cell Transplantation Unit, Gene and Cell Therapy Center “George Papanikolaou” Hospital Thessaloniki Greece

2. Department of Genetics, Development and Molecular Biology, School of Biology Aristotle University of Thessaloniki Thessaloniki Greece

3. Blood Bank Department General Hospital of Pella‐Giannitsa Giannitsa Greece

4. Department of Medicine University of Washington Seattle Washington USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.175

Reference62 articles.

1. T cells for viral infections after allogeneic hematopoietic stem cell transplant

2. Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective